DexCom has filed a patent for a system and method of continuous analyte measurement in a host’s vascular system. The system includes a vascular access device, a sensor, and sensor electronics that can be inserted into the host’s circulatory system. The patent claim describes a system with a transcutaneous analyte sensor and sensor electronics that connect to the sensor. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights DexCom Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on DexCom, Medical data analysis was a key innovation area identified from patents. DexCom's grant share as of September 2023 was 45%. Grant share is based on the ratio of number of grants to total number of patents.

Continuous analyte measurement system with transcutaneous sensor and electronics

Source: United States Patent and Trademark Office (USPTO). Credit: DexCom Inc

A recently filed patent (Publication Number: US20230309881A1) describes a system and method for measuring the concentration of an analyte in a host. The system includes a transcutaneous analyte sensor and sensor electronics that can be connected to the sensor. This system aims to provide a non-invasive way of measuring analyte concentration in the body.

The first claim of the patent describes the system itself. It consists of a transcutaneous analyte sensor, which is a device that can measure the concentration of an analyte in the body through the skin. The sensor electronics are designed to connect to the transcutaneous analyte sensor, allowing for the collection and processing of data.

The second claim focuses on the method for processing data from the transcutaneous analyte sensor. The method involves receiving sensor data that indicates the concentration of the analyte in the host's body. This data is then processed using a processor, which likely involves analyzing and interpreting the information to provide meaningful results.

Overall, this patent aims to provide a system and method for measuring analyte concentration in a non-invasive manner. By utilizing a transcutaneous analyte sensor and sensor electronics, the system can collect and process data to determine the concentration of the analyte in the host's body. This technology could have potential applications in various fields, such as healthcare and medical monitoring, where non-invasive measurements are desirable. However, it is important to note that the patent claims do not provide specific details about the analyte being measured or the specific implementation of the system and method.

To know more about GlobalData’s detailed insights on DexCom, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies